Originally posted by Rondec The thing is that epinephrine has been generic for a long time. It is the convenience of the device that epi pen uses that is being sold at an exorbitant price. And I guess the patent on that device goes off patent soon?
We saw this a few years ago when they took meter dose inhalers off the market for albuterol. They were generic and cost maybe 10 dollars for an inhaler. Unfortunately they contained CFCs and when they replaced them with hydrofluoroalkane (HFA) inhalers the price jumped to 70 or 80 dollars an inhaler. The issue wasn't the medicine which was still really cheap, it was the device to the deliver the medicine.
The patents on the Epi-pen, as I understand it, aren't going to expire soon, as they have updated the patents with each incremental improvement. The profit is absolutely on the injector, not the drug itself. For a well-researched essay on the subject, including the way-back-when origin of the device, may I recommend
this link - very much non-partisan and pulls no punches about anything...
Jim